Patents by Inventor Anna Kalota

Anna Kalota has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells
    Patent number: 8530508
    Abstract: The present invention provides methods of inhibiting human myeloid leukemia cell growth and proliferation by administering a thrombopoietin receptor agonist (TpoRA), a derivative, or variant thereof, to an individual with AML.
    Type: Grant
    Filed: October 8, 2008
    Date of Patent: September 10, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Alan Gewirtz, Anna Kalota, Connie L. Erickson-Miller
  • THROMBOPOIETIN RECEPTOR AGONIST (TPORA) KILLS ACUTE HUMAN MYELOID LEUKEMIA CELLS
    Publication number: 20100298398
    Abstract: The present invention provides methods of inhibiting human myeloid leukemia cell growth and proliferation by administering a thrombopoietin receptor agonist (TpoRA), a derivative, or variant thereof, to an individual with AML.
    Type: Application
    Filed: October 8, 2008
    Publication date: November 25, 2010
    Inventors: Alan Gewirtz, Anna Kalota, Connie L. Erickson-Miller